ARCHIVES

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

O’Neill Recounts Private Meeting To Increase Cancer Appropriations

May 3, 1991

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

Adriamycin Fact Sheet Available

July 4, 1975

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008